Acutus Medical announced Steven Mickelsen, a pioneer in the field of pulse field ablation (PFA) technology, his departure as Chief Translational Science Officer at Acutus Medical to re-focus efforts on his passion for patient care and new cardiac device innovation. Dr. Mickelsen will now dedicate additional time caring for heart-rhythm patients at his clinical practice at Scripps Medical Center in La Jolla California. He will also continue educating the next generation of medical professionals as Associate Professor of internal medicine at the University of Iowa, a position he has maintained since 2014 .

In the fourth quarter of 2022, Dr. Mickelsen will begin anew business venture called Field Medical to create the next generation of cardiac ablation technology. Seed funding is currently being secured along with the establishment of Board of Directors and senior leadership team, of which he intends to have a role. Additional details will be made available at that time.

Most recently, Dr. Mickelsen lead a design team at Acutus to advance a PFA waveform development to expand the capabilities of the existing AcQblate contact-force ablation catheter. The program was highly successful resulting in the PFA-CE clinical trials ongoing in Europe.